Follow-up and prognosis of HCM

Authors

  • Fernando Dominguez Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Manuel de Falla, Majada- honda, Madrid, Spain
  • Jorge Sanz-Sánchez Hospital Universitario y Politécnico La Fe, Valencia, Spain
  • Pablo García-Pavía Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Manuel de Falla, Majada- honda, Madrid, Spain
  • Esther Zorio Hospital Universitario y Politécnico La Fe, Valencia, Spain

DOI:

https://doi.org/10.21542/gcsp.2018.33

Abstract

[first paragraph of article]

The frequency of follow-up visits in hypertrophic cardiomyopathy (HCM) patients is mainly determined by their symptoms, age and severity of disease. Clinical visits should focus on sudden cardiac death (SCD) and embolic risk-assessment, changes in symptoms, cardiac rhythm, left ventricular outflow tract obstruction (LVOTO) and left ventricular (LV) systolic function.

Downloads

Published

2018-10-24

Issue

Vol. 2018 No. 3 (2018)

Section

Review articles

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.